Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes

NCT00803530 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

55

Enrollment

OTHER

Sponsor class

Stopped difficulties of enrollement

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: ATO + Ascorbic acid

Sponsor

Fondazione Italiana Sindromi Mielodisplastiche-ETS

Collaborators

[object Object]